Brief: Better Therapeutics Announces Publication Of Livvita Liver Disease Study Results In Gastro Hep Advances
05/10/2023 13:09
Oct 5 (Reuters) - Better Therapeutics Inc BTTX.O :
* BETTER THERAPEUTICS ANNOUNCES PUBLICATION OF LIVVITA LIVER
DISEASE STUDY RESULTS IN GASTRO HEP ADVANCES
* BETTER THERAPEUTICS INC - COMPANY EXPECTS TO SUBMIT
REQUEST TO
FDA FOR BREAKTHROUGH DEVICE DESIGNATION IN Q4 2023
Source text for Eikon: ID:nBw8vZGFka
Further company coverage: BTTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Better Therapeutics
See all newsU.S. STOCKS ON THE MOVE-WiSA Technologies, Rivian Automotive, Cigna Group
U.S. STOCKS ON THE MOVE-Morgan Stanley, Intra-Cellular Therapies, China SXT Pharmaceuticals
U.S. STOCKS ON THE MOVE-Snap One, Encore Wire, Centene
U.S. STOCKS ON THE MOVE-Cisco Systems, Inspired Entertainment, Spirit Airlines
U.S. STOCKS ON THE MOVE-G-III Apparel Group, Tesla, MicroStrategy